Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Consultas o comentarios: productividad@anid.cl
A plain language summary on ritlecitinib treatment for adults and adolescents with alopecia areata
| Indexado |
|
||||
| DOI | 10.2217/IMT-2023-0069 | ||||
| Año | 2023 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Abstract
Ritlecitinib was an effective and well-tolerated treatment over 48 weeks for people with AA.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | King, Brett | - |
Yale Univ Sch Med - Estados Unidos
Yale School of Medicine - Estados Unidos |
| 2 | Zhang, Xingqi | - |
Sun Yat Sen Univ - China
Sun Yat-Sen University - China |
| 3 | Harcha, Walter Gubelin | Hombre |
Ctr Med Skinmed - Chile
Centro Médico SKINMED - Chile |
| 4 | Szepietowski, Jacek C. | - |
Wroclaw Med Univ - Polonia
Wroclaw Medical University - Polonia |
| 5 | Shapiro, Jerry | Hombre |
NYU Sch Med - Estados Unidos
NYU Grossman School of Medicine - Estados Unidos |
| 6 | Lynde, Charles W. | Hombre |
UNIV TORONTO - Canadá
University of Toronto - Canadá University of Toronto Faculty of Medicine - Canadá |
| 7 | Mesinkovska, Natasha A. | - |
Univ Calif Irvine - Estados Unidos
UCI School of Medicine - Estados Unidos |
| 8 | Zwillich, Samuel H. | - |
Pfizer Inc - Estados Unidos
Pfizer Inc. - Estados Unidos |
| 9 | Napatalung, Lynne | - |
Pfizer Inc - Estados Unidos
Icahn Sch Med Mt Sinai - Estados Unidos Icahn School of Medicine at Mount Sinai - Estados Unidos Pfizer Inc. - Estados Unidos |
| 10 | Wajsbrot, Dalia | Mujer |
Pfizer Inc - Estados Unidos
Pfizer Inc. - Estados Unidos |
| 11 | Fayyad, Rana | - |
Pfizer Inc - Estados Unidos
Pfizer Inc. - Estados Unidos |
| 12 | Freyman, Amy | - |
Pfizer Inc - Estados Unidos
Pfizer Inc. - Estados Unidos |
| 13 | Mitra, Debanjali | - |
Pfizer Inc - Estados Unidos
Pfizer Inc. - Estados Unidos |
| 14 | Purohit, Vivek | - |
Pfizer Inc - Estados Unidos
Pfizer Inc. - Estados Unidos |
| 15 | Sinclair, Rodney | Hombre |
Sinclair Dermatol - Australia
Sinclair Dermatology - Australia |
| 16 | Wolk, Robert | Hombre |
Pfizer Inc - Estados Unidos
Pfizer Inc. - Estados Unidos |
| Agradecimiento |
|---|
| The study and this summary were funded by Pfizer Inc. |
| The authors thank all patients who participated in the ALLEGRO-2b/3 trial and their families, as well as the trial investigators and staff at the clinical sites. Writing support for this summary was provided by Ellen Mercado, PhD, of Health Interactions, Inc., and was funded by Pfizer Inc. Financial & competing interests disclosure |
